Chromomycin A3 staining, sperm chromatin structure assay and hyaluronic acid binding assay as predictors for assisted reproductive outcome☆
Abstract
Functional sperm tests such as the sperm chromatin structure assay (SCSA), chromomycin A3 staining (CMA3) and hyaluronic acid binding assay (HBA) have been suggested as predictive tests of fertility in vitro. This study aimed to define the clinical role of these functional parameters in assisted reproduction in a prospective cohort study. Conventional sperm diagnosis (motility, morphology and concentration) as well as SCSA, CMA3 and HBA tests were performed on 205 semen samples [74 IVF, 94 ICSI and 37 combined IVF/intracytoplasmic sperm injection (ICSI)]. Main outcome parameters were fertilization rate, clinical pregnancy rate and take-home baby rate. The study showed that each of the three functional sperm tests was related to one or more conventional and one or more functional sperm tests, indicating that spermatozoa from patients with abnormal conventional semen parameters have a higher likelihood for multiple functional abnormalities. Only SCSA and CMA3 staining were shown to have a limited predictive value when IVF or combined IVF/ICSI was applied. The proposed threshold value of
15% for predicting good fertilization rates and obtaining a pregnancy in IVF could only be confirmed for percent HDS (high DNA stainability in SCSA). ICSI outcome was not influenced by any of the conventional or functional sperm parameters.
Keywords: CMA3, DNA fragmentation, IVF/ICSI outcome, SCSA, sperm morphology, sperm quality
To access this article, please choose from the options below
Martine Nijs obtained her PhD in Medical Sciences at the Free University of Brussels in Belgium. She is ESHRE accredited senior clinical embryologist. At present, she is the director of the IVF laboratory at the Genk Institute for Fertility Technology in Genk, Belgium. Her main interests are sperm quality, sperm freezing and human embryology. Dr Martine Nijs
☆ Partially presented as an oral communication (0–165) at the 21st Meeting of ESHRE, Copenhagen, Denmark, 19–22, June 2005.Partially presented as a poster at the 31st Annual Meeting of the American Society of Andrology, Chicago, USA, April 8–11, 2006.Partially presented as a poster at the Satellite Sperm DNA workshop in Rome, 11–13 March, 2009.
PII: S1472-6483(09)00064-9
doi:10.1016/j.rbmo.2009.07.002
© 2009 Reproductive Healthcare Ltd, Duck End Farm, Dry Drayton, Cambridge CB23 8DB, UK. Published by Elsevier Inc. All rights reserved.
